Retrospective study identifies imaging features that discriminate between lung cancers in patients.
Background/Objectives: Distinguishing primary lung squamous cell carcinoma (PLSCC) from metastatic head and neck squamous cell carcinoma (MHNSCC) to the lungs is challenging for pathologists, especially when patients present with a solitary lung nodule. The purpose of this study was to identify CT imaging features that differ between PLSCC from solitary MHNSCC to the lungs, using next-generation sequencing (NGS) and human papillomavirus in situ hybridization analysis as the gold reference standard. Methods: This retrospective, single-institution cross-sectional study included patients with a biopsy-proven PLSCC or solitary MHNSCC from July 2013 to May 2022, who underwent NGS or in situ hybridization, and baseline CT or PET/CT. Each scan was evaluated by at least two radiologists. Nodular, pleural, and ancillary CT features, as well as maximum standardized uptake value (SUVmax) from PET/CTs, were recorded. Associations between imaging features and pathology were examined using either the Wilcoxon rank-sum or Fisher’s exact test. Results: In total, 81 patients were included (median 66 years; 64 male); 36/81 (44%) had PLSCC and 45/81 (56%) had MHNSCC. PLSCC was associated with a larger size (median, 3.3–3.6 cm vs. 1.4–1.6 cm, p < 0.001), and the presence of post obstructive atelectasis (p = 0.002), pleural retraction (p < 0.001), pleural tags (p = 0.02), and pleural surface involvement (p = 0.02). MHNSCC presented as smaller peripheral nodules (p = 0.003) with lower SUVmax (p = 0.01). Conclusions: Several CT imaging features as well as SUVmax from PET/CT were significantly different between PLSCC and solitary MHNSCC and their potential discriminatory ability warrants evaluation in future studies.
No takes yet. Share an insight, caveat, or question.
Oliveira et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: